• Revenue Cycle Management
  • COVID-19
  • Diabetes Awareness Month
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Q&A: Roth IRA changes possible

Article

It is possible for Congress to pass legislation taking away an anticipated benefit such as income-tax-free treatment of Roth IRAs.

Q Could you speak to the issue of a possible change in the rules on Roth IRAs that may occur in the future? Apparently, the government can impose taxes on these accounts in numerous ways, or change the rules in a material way that would make conversion a bad idea. Can you provide any insight on this possible negative aspect of a conversion? I am based in New York.

A. It is possible for Congress to pass legislation taking away an anticipated benefit such as income-tax free treatment of Roth IRAs. For example, although currently no federal estate tax exists, there is significant discussion about imposing a tax retroactive to January 1, 2010. With that said, in my 26 years practicing as a tax attorney, I have observed that in almost all situations in which a benefit is taken away, it is eliminated prospectively, not retroactively. In this situation, a future change could be preventing future Roth contributions or conversions and likely would not involve terminating the tax-free status of past conversions.

Related Videos
Jolie Apicella, JD
David Zetter gives expert advice
David Zetter gives expert advice
Joel Greenwald, MD, CFP
Ben Johnston gives expert advice
Ben Johnston gives expert advice
Ben Johnston gives expert advice
Ben Johnston gives expert advice
Ben Johnston gives expert advice
© 2023 MJH Life Sciences

All rights reserved.